University of Patras
Μοριακές μελέτες κατά την επίδραση της προχορήγησης του σεβοφλουράνιου στην ηπατική και πνευμονική βλάβη από ισχαιμία/επαναιμάτωση ήπατος σε μοντέλο αρουραίων
Abstract
dc:descriptionSevoflurane has been shown to improve ischemia/reperfusion injury (IRI) through several mechanisms, including amelioration of inflammatory response. However, there haven’t been any studies considering the potential role of the complement system in sevoflurane-mediated amelioration of ischemia/reperfusion injury. Our purpose was to investigate the molecular mechanisms of the inflammation involved in sevoflurane preconditioning in liver and lung injury induced by liver ischemia-reperfusion (LIR). For this purpose, fifty male Wistar rats were randomly allocated in five groups (n=10 each): Animals in group LIR received ketamine and xylazine and were then subjected to ischemia of the right and median hepatic lobe for 45 min and reperfusion for 6 h. Group SEVO/LIR also received anesthesia with ketamine and xylazine and additionally, animals received sevoflurane for 30 min. and then LIR was induced, as in group LIR. Animals in group SHAM/LIR were anesthetized with ketamine and xylazine and then laparotomy followed. Group SHAM/SEVO received anesthesia with sevoflurane for 30 min. and then laparotomy followed. Finally, in group VEN, animals only received ketamine and xylazine.Afterwards, bronchoalveolar lavage fluid (BALF) was obtained to measure cell counts. Liver function parameters and plasma complement C3 levels in serum were determined. Histologic changes both in liver and lung and CASP3 and ICAM1 deposition in those tissues sections were examined. Expression of complement C3 and C5 mRNA, along with ICAM1 and CLU mRNA was analyzed by quantitative real-time –PCR.Our study showed that sevoflurane preconditioning significantly improved liver-function tests (decreased ALT, AST and ALP levels) and limited inflammatory cell infiltration in BALF. Additionally, compared with the LIR group, the plasma C3 levels, were significantly reduced in the SEVO/LIR group. No stastically significant differences were observed in histological examination in the liver and lung. Immunostaining of the liver for ICAM1 however, showed a decrease in the membranse isoform of ICAM1 in the SEVO/LIR group. In the lung, sevoflurane seemed to exert no effect in ICAM1 levels. CASP3 levels in the liver and the lung also appeared unaffected by sevoflurane preconditioning. In the SEVO/LIR group, ICAM1 mRNA levels were found significantly decreased in the liver. No statistical significantly differences were observed in C3, C5 and CLU mRNA levels in any tissue.Summarising, sevoflurane preconditioning seems to ameliorate LIR-induced inflammatory injury both in the liver and in the lung, mediated, at least partially, by the C3 and ICAM-1 molecules. Further studies are needed to shed light into the underlying mechanisms and the potential of the application of sevoflurane preconditioning in the clinical praxis.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mikrou, Angeliki
- Μικρού, Αγγελική
Subjects
dc:subject × 8Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39565